Network Meta-Analysis To Assess The Relative Efficacy And Safety of Linagliptin, Empagliflozin And The Fixed Dose Combination of Empagliflozin And Linagliptin In Patients With Type 2 Diabetes Mellitus (T2DM)

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1844
https://www.valueinhealthjournal.com/article/S1098-3015(16)33210-7/fulltext
Title : Network Meta-Analysis To Assess The Relative Efficacy And Safety of Linagliptin, Empagliflozin And The Fixed Dose Combination of Empagliflozin And Linagliptin In Patients With Type 2 Diabetes Mellitus (T2DM)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33210-7&doi=10.1016/j.jval.2016.09.1844
First page : A667
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1744
Categories :
Tags :
Regions :
ViH Article Tags :